Cargando…
Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
BACKGROUND: Clostridioides difficile is the leading health care–associated pathogen, but clinicians lack a test that can reliably differentiate colonization from infection. Health care costs attributed to C. difficile are substantial, but the economic burden associated with C. difficile false positi...
Autores principales: | Madden, Gregory R, Smith, David C, Poulter, Melinda D, Sifri, Costi D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863872/ https://www.ncbi.nlm.nih.gov/pubmed/33575420 http://dx.doi.org/10.1093/ofid/ofaa630 |
Ejemplares similares
-
Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool
por: Madden, Gregory R, et al.
Publicado: (2020) -
Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention
por: Madden, Gregory R., et al.
Publicado: (2019) -
Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes
por: Madden, Gregory R., et al.
Publicado: (2022) -
754. A Two-step Testing Algorithm for Hospital-onset Clostridioides difficile Infection (CDI) Reduces Prescribing of C. difficile (CD) Therapy but Its Ability to Guide Treatment Decisions Remains Unclear
por: Dolan, Mackenzie, et al.
Publicado: (2021) -
Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease
por: Young, Mary K, et al.
Publicado: (2022)